Scientia Vascular
West Valley City, US · Delaware corporation · 3 known investors
Scientia Vascular develops guidewires, including the Aristotle and Zoom Wire product lines, for general vascular use within the neuro and peripheral vasculatures to introduce and position catheters and other interventional devices. The single-use, sterile devices are intended for physicians trained in percutaneous interventional techniques and are not for coronary use.
Founders & leadership
JL
John LippertNamed on SEC filing
SL
Stacy LippertNamed on SEC filing
Board
JG
Jeffrey GladdenDr. Gladden is a manager of the issuer.
DB
David BearssMr. Bearss is a manager of the issuer.
RR
Rick RandallMr. Randall is a manager of the issuer.
JH
Jerry HenleyMr. Henley is a manager of the issuer.
DL
De Lyle BloomquistMr. Bloomquist is a manager of the issuer.
HM
Huy M. DoDr. Do is a manager of the issuer.
Investors · 3
Also in the syndicate · 1
Piper Sandler Merchant Bankinglead
Funding
SEC filings, press & company announcements$69M disclosed across 3 rounds · 2021–2024
- $14MraisedSep 2024 · 2 sources
Piper Sandler Merchant Banking (lead)
Source ↗
▶$5MraisedNov 2023 · 29 investors · Other Health CareRule 506(c)
▶$5MraisedNov 2023 · 29 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Joseph SilettoDirector
- Mahendra ShahDirector
- Janet LoweDirector
- Huy M. DoDirector
- Nathan DauDirector
- Jeffrey GladdenDirector
- John LippertExecutive Officer, Director
- Stacy LippertExecutive Officer, Director
- Larry MyresExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $780
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$50MraisedJun 2021 · 1 investors · Other Health CareRule 506(b)
▶$50MraisedJun 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey GladdenDirector
- David BearssDirector
- John LippertExecutive Officer, Director
- Rick RandallDirector
- Stacy LippertExecutive Officer, Director
- Jerry HenleyDirector
- De Lyle BloomquistDirector
- Huy M. DoDirector
- Offering amount
- $50M
- Amount sold
- $50M
- Minimum investment
- $50M
- First sale
- May 2021
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 8
by search overlap
Rf Surgical13 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Boston Scientific10 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Read the Press Release10 shared keywordsStryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.
Access Vascular7 shared keywordsAccess Vascular develops thrombus-evading intravascular catheters made from a proprietary biomaterial, offering an FDA-cleared PICC and the HydroMID peripherally inserted midline catheter to reduce vascular access complications. The company designs and manufactures its medical devices for clinical use in the United States.
NeuroVasc5 shared keywordsNeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions. The company serves patients and healthcare providers requiring neurovascular interventions.
Innova Vascular5 shared keywordsInnova Vascular is a medical device company focused on the vascular space, led by a founder with a background in developing and commercializing vascular medical devices. The page provides limited detail about the company's specific products.
Imperative Care Inc4 shared keywordsImperative Care develops medical technologies for treating stroke and other vascular diseases, aiming to address gaps across the patient care journey. The company focuses on devices and solutions for patients suffering from devastating vascular conditions.
Vantis Vascular4 shared keywordsVantis Vascular develops vascular intervention technology, including the CrossFast integrated vascular delivery system with an auto-locking inner monorail microcatheter and outer delivery catheter for complex PCI procedures. Founded by physicians, the company is also developing next-generation intravascular lithotripsy (IVL) and peripheral below-the-knee (BTK) solutions for vascular interventionalists.</parameter>
<parameter name="founders">[{"full_name": "Jason Turner", "title": "Chief Executive Officer"}, {"full_name": "Tim Fischell", "title": "Chief Medical Officer"}, {"full_name": "Frank Saltiel", "title": "Chief Clinical Officer"}, {"full_name": "Gary McCord", "title": "Chief Commercial Officer"}, {"full_name": "Mike Mirizzi", "title": "Chief Technology Officer"}, {"full_name": "Marc Monahan", "title": "Chief Financial Officer"}]</parameter>
<parameter name="hq_city">San Jose
Companies competing with Scientia Vascular for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Scientia Vascular do?
- Scientia Vascular develops guidewires, including the Aristotle and Zoom Wire product lines, for general vascular use within the neuro and peripheral vasculatures to introduce and position catheters and other interventional devices. The single-use, sterile devices are intended for physicians trained in percutaneous interventional techniques and are not for coronary use.
- Who are Scientia Vascular's investors?
- Scientia Vascular's investors include Cowles Ventures, Vivo Capital.
- How much funding has Scientia Vascular raised?
- Scientia Vascular has disclosed $69M raised across 3 rounds.
- Where is Scientia Vascular headquartered?
- Scientia Vascular is headquartered in West Valley City, US.